These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 21035400)

  • 1. Energy metabolism in amyotrophic lateral sclerosis.
    Dupuis L; Pradat PF; Ludolph AC; Loeffler JP
    Lancet Neurol; 2011 Jan; 10(1):75-82. PubMed ID: 21035400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.
    Perera ND; Turner BJ
    Neurochem Res; 2016 Mar; 41(3):544-53. PubMed ID: 26202426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS) patients.
    Genton L; Viatte V; Janssens JP; Héritier AC; Pichard C
    Clin Nutr; 2011 Oct; 30(5):553-9. PubMed ID: 21798636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is "Hyper" in the ALS Hypermetabolism?
    Ferri A; Coccurello R
    Mediators Inflamm; 2017; 2017():7821672. PubMed ID: 29081604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.
    Dupuis L; Loeffler JP
    Curr Opin Pharmacol; 2009 Jun; 9(3):341-6. PubMed ID: 19386549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revisiting the concept of amyotrophic lateral sclerosis as a multisystems disorder of limited phenotypic expression.
    Strong MJ
    Curr Opin Neurol; 2017 Dec; 30(6):599-607. PubMed ID: 28914734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
    Dupuis L; Gonzalez de Aguilar JL; Oudart H; de Tapia M; Barbeito L; Loeffler JP
    Neurodegener Dis; 2004; 1(6):245-54. PubMed ID: 16908975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between estimated total daily energy expenditure and stage of amyotrophic lateral sclerosis.
    Lee J; Baek H; Kim SH; Park Y
    Nutrition; 2017 Jan; 33():181-186. PubMed ID: 27544003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy metabolism in ALS: an underappreciated opportunity?
    Vandoorne T; De Bock K; Van Den Bosch L
    Acta Neuropathol; 2018 Apr; 135(4):489-509. PubMed ID: 29549424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: new insights into underlying molecular mechanisms and opportunities for therapeutic intervention.
    Cozzolino M; Pesaresi MG; Gerbino V; Grosskreutz J; Carrì MT
    Antioxid Redox Signal; 2012 Nov; 17(9):1277-330. PubMed ID: 22413952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis: the role of exercise.
    Lisle S; Tennison M
    Curr Sports Med Rep; 2015 Jan; 14(1):45-6. PubMed ID: 25574882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the mechanisms of copper dyshomeostasis in amyotrophic lateral sclerosis.
    Gil-Bea FJ; Aldanondo G; Lasa-Fernández H; López de Munain A; Vallejo-Illarramendi A
    Expert Rev Mol Med; 2017 Jun; 19():e7. PubMed ID: 28597807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and therapeutic perspectives in amyotrophic lateral sclerosis.
    Mathis S; Couratier P; Julian A; Vallat JM; Corcia P; Le Masson G
    Expert Rev Neurother; 2017 Mar; 17(3):263-276. PubMed ID: 27644548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrient Effects on Motor Neurons and the Risk of Amyotrophic Lateral Sclerosis.
    Goncharova PS; Davydova TK; Popova TE; Novitsky MA; Petrova MM; Gavrilyuk OA; Al-Zamil M; Zhukova NG; Nasyrova RF; Shnayder NA
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Amyotrophic lateral sclerosis--electrophysiologic aspects of its pathophysiology and new therapeutic options].
    Kuwabara S
    Brain Nerve; 2010 Aug; 62(8):885-91. PubMed ID: 20714037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis.
    Dupuis L; Corcia P; Fergani A; Gonzalez De Aguilar JL; Bonnefont-Rousselot D; Bittar R; Seilhean D; Hauw JJ; Lacomblez L; Loeffler JP; Meininger V
    Neurology; 2008 Mar; 70(13):1004-9. PubMed ID: 18199832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional and metabolic support in patients with amyotrophic lateral sclerosis.
    Muscaritoli M; Kushta I; Molfino A; Inghilleri M; Sabatelli M; Rossi Fanelli F
    Nutrition; 2012 Oct; 28(10):959-66. PubMed ID: 22677356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of exercise in amyotrophic lateral sclerosis.
    Chen A; Montes J; Mitsumoto H
    Phys Med Rehabil Clin N Am; 2008 Aug; 19(3):545-57, ix-x. PubMed ID: 18625415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcranial direct current stimulation does not modulate motor cortex excitability in patients with amyotrophic lateral sclerosis.
    Munneke MA; Stegeman DF; Hengeveld YA; Rongen JJ; Schelhaas HJ; Zwarts MJ
    Muscle Nerve; 2011 Jul; 44(1):109-14. PubMed ID: 21674525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.